News Grifols files drug for rare bleeding disorder in the US Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.
News Grifols eyes first place in US fibrinogen concentrate market Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatmen
News NHS records to be harnessed in pancreatic cancer screening The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face